المؤلفون: Wilson I. Gonsalves, S. Vincent Rajkumar, Jessica Haug, Kevin C. Miller, Vijay Ramakrishnan, Sanjay Kumar, Teresa K. Kimlinger, Shaji Kumar, Elaine P. Macon

المصدر: Haematologica

مصطلحات موضوعية: Apoptosis, Article, Plasma Cell Disorders, Romidepsin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cell Line, Tumor, hemic and lymphatic diseases, Panobinostat, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multiple myeloma, 030304 developmental biology, 0303 health sciences, biology, Entinostat, Venetoclax, Hematology, MAP Kinase Kinase Kinases, medicine.disease, 3. Good health, Histone Deacetylase Inhibitors, Histone, Proto-Oncogene Proteins c-bcl-2, chemistry, 030220 oncology & carcinogenesis, Mutation, ras Proteins, biology.protein, Selumetinib, Cancer research, Benzimidazoles, raf Kinases, Histone deacetylase, Multiple Myeloma, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c3f72fd3b93c9bc750660be71c8d627
https://doi.org/10.3324/haematol.2018.211110

المؤلفون: P. Leif Bergsagel, Ronald S. Go, Prashant Kapoor, David Dingli, Angela Dispenzieri, Francis K. Buadi, Alese E. Halvorson, Suzanne R. Hayman, Morie A. Gertz, Yi Lin, Martha Q. Lacy, Candido E. Rivera, Joseph R. Mikhael, Shaji Kumar, Thomas E. Witzig, Yi L. Hwa, S. Vincent Rajkumar, Vivek Roy, Wilson I. Gonsalves, Betsy LaPlant, Sikander Ailawadhi, Craig B. Reeder, Keith Stewart, Jamie Crawley, Melanie Ann Thompson

المصدر: Blood. 128:2415-2422

مصطلحات موضوعية: Boron Compounds, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Clinical Trials and Observations, Immunology, Glycine, Pharmacology, Biochemistry, Dexamethasone, Ixazomib, law.invention, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Cell Biology, Hematology, Middle Aged, medicine.disease, Survival Analysis, Treatment Outcome, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Toxicity, Proteasome inhibitor, Female, Neoplasm Recurrence, Local, Multiple Myeloma, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ce9b3713d8f7b62d298f3264ef2655
https://doi.org/10.1182/blood-2016-05-717769

المؤلفون: Betsy LaPlant, Miriam Hobbs, A. Keith Stewart, Martha Q. Lacy, Angela Dispenzieri, P. Leif Bergsagel, Francis K. Buadi, David Dingli, Nelson Leung, Joseph R. Mikhael, Yi Lisa Hwa, Morie A. Gertz, Suzanne R. Hayman, Ronald S. Go, Rafael Fonseca, Alese E. Halvorson, Prashant Kapoor, Tomas Skacel, Wilson I. Gonsalves, Amie Fonder, Yi Lin, John A. Lust, Shaji Kumar, S. Vincent Rajkumar, Craig B. Reeder

المصدر: Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 8, Pp 1-10 (2018)

مصطلحات موضوعية: 0301 basic medicine, Adult, Boron Compounds, Male, medicine.medical_specialty, Cyclophosphamide, medicine.medical_treatment, Glycine, Hematopoietic stem cell transplantation, lcsh:RC254-282, Gastroenterology, Dexamethasone, Article, Ixazomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, Multiple myeloma, Aged, Neoplasm Staging, Aged, 80 and over, Bortezomib, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Combined Modality Therapy, 3. Good health, 030104 developmental biology, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Proteasome inhibitor, Female, business, Multiple Myeloma, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f53b35e7b7a2e4030ba75049459ac3
https://pubmed.ncbi.nlm.nih.gov/30061664

المؤلفون: P. Leif Bergsagel, Svetomir N. Markovic, John A. Lust, Craig B. Reeder, David Dingli, Yi Lin, Angela Dispenzieri, William G. Morice, Taimur Sher, David J. Inwards, Rebecca L. King, Patricia T. Greipp, Stephen M. Ansell, Shaji Kumar, Yi L. Hwa, Asher Chanan-Khan, Ann Novak, Dragan Jevremovic, Ivana N. Micallef, Martha Q. Lacy, Morie A. Gertz, Suzanne R. Hayman, Steven R. Zeldenrust, Ronald S. Go, Wilson I. Gonsalves, Michelle L. Mauermann, Grzegorz S. Nowakowski, Thomas M. Habermann, Carrie A. Thompson, Luis F. Porrata, Esteban Braggio, A. Keith Stewart, Thomas E. Witzig, Prashant Kapoor, Joseph P. Colgan, S. Vincent Rajkumar, Vivek Roy, Sikander Ailawadhi, Patrick B. Johnston, Robert A. Kyle, Martha Grogan, Steven Russell, Nelson Leung, Rhett P. Ketterling, Rafael Fonseca, Francis K. Buadi, Joseph R. Mikhael

المصدر: JAMA Oncology. 3:1257

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Risk Assessment, Article, Dexamethasone, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Autologous stem-cell transplantation, Piperidines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Everolimus, Cyclophosphamide, Plasma Exchange, business.industry, Adenine, Waldenstrom macroglobulinemia, Macroglobulinemia, medicine.disease, Surgery, Clinical trial, Pyrimidines, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Myeloid Differentiation Factor 88, Retreatment, Pyrazoles, Rituximab, Waldenstrom Macroglobulinemia, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f82f3a45b2b41ab85040854c541005
https://doi.org/10.1001/jamaoncol.2016.5763